Technology | Guidewires | February 19, 2016

Nipro Medical Corp. Launches AquaLiner II Nitinol Guidewire in the U.S.

Hydrophilic, super-elastic second-generation guidewire provides control needed to navigate complex lesions

February 19, 2016 — Nipro North America announced the launch of the AquaLiner II second-generation 0.035-inch, hydrophilic, super-elastic nitinol guidewire. The guidewire enables the operator to navigate through complex lesions and deliver interventional devices such as balloons and stents.

AquaLiner II's improved, kink-resistant nitinol core provides the control needed to navigate the vasculature by absorbing strain and maintaining strength. The super-elasticity of the device’s core wire conforms to the patient's vasculature and provides excellent support for interventional devices.

The guidewire's hydrophilic coating delivers the durability required to maintain lubricity throughout the procedure even through multiple passes. AquaLiner II also delivers ienhanced tactile feel, pushability and trackability, even in the most challenging anatomy.

The chemically-engineered tip delivers a smooth, atraumatic insertion and navigation through vessels. Minimal force is required, allowing for better steerability and control. The tapered tip also provides optimal stability, while still maintaining a flexible soft taper.

AquaLiner II is available in various lengths, ranging from 150cm to 260cm, with a regular or stiff-configured wire and with a straight or angled tip.

For more information: www.nipro.com


Related Content

Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
News | Cath Lab

Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...

Home September 23, 2025
Home
Subscribe Now